Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method
- PMID: 6204498
- DOI: 10.1111/j.1600-0404.1984.tb07804.x
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method
Abstract
Catecholamines and indolealkylamines are of clinical interest in neurological and psychiatric disorders. We measured 3-methoxy-DOPA, 3-methoxy-4-hydroxyphenylglycol, dihydroxyphenylacetic acid, tryptophan, 5-hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid with a simple, sensitive , inexpensive, rapid and accurate procedure using high performance liquid chromatography coupled to an electrochemical detector. Patients with Parkinson's disease have a decrement in homovanillic acid that is reversed by treatment with L-3,4-dihydroxyphenylalanine. After this medication, 3-methoxy-DOPA is measurable in cerebrospinal fluid. Patients with depression show a decrease in serotonin turnover expressed by diminished 5-hydroxyindoleacetic acid content in cerebrospinal fluid. Depressed patients also show low levels of tryptophan. Monoamine metabolites are augmented in patients with subarachnoid hemorrhage.
Similar articles
-
Simultaneous determination of four monoamine metabolites and serotonin in cerebrospinal fluid by "high-performance" liquid chromatography with electrochemical detection; application for patients with Alzheimer's disease.Clin Chem. 1988 Apr;34(4):680-4. Clin Chem. 1988. PMID: 2452037
-
Role of neurotransmitter in forensic medicine (report II). A simple and simultaneous analysis of the major monoamine metabolites in human cerebrospinal fluid by high performance liquid chromatography with electrochemical detection.Nihon Hoigaku Zasshi. 1987 Feb;41(1):4-9. Nihon Hoigaku Zasshi. 1987. PMID: 2439728 No abstract available.
-
Postmortem changes in the levels of monoamine metabolites in human cerebrospinal fluid.Forensic Sci Int. 1990 Jan;44(1):61-8. doi: 10.1016/0379-0738(90)90168-x. Forensic Sci Int. 1990. PMID: 1689267
-
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.Brain Res. 1974 Oct 11;79(1):1-8. doi: 10.1016/0006-8993(74)90562-9. Brain Res. 1974. PMID: 4279131 Review. No abstract available.
-
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?Med Biol. 1985;63(1):1-17. Med Biol. 1985. PMID: 2582215 Review.
Cited by
-
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease.J Neural Transm (Vienna). 2006 Nov;113(11):1763-9. doi: 10.1007/s00702-006-0485-7. Epub 2006 Jun 1. J Neural Transm (Vienna). 2006. PMID: 16736242
-
Depression in Parkinson's disease. Pharmacological characteristics and treatment.Drugs Aging. 1998 Jan;12(1):55-74. doi: 10.2165/00002512-199812010-00006. Drugs Aging. 1998. PMID: 9467687 Free PMC article. Review.
-
CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.Neurology. 2023 Mar 7;100(10):e1009-e1019. doi: 10.1212/WNL.0000000000201647. Epub 2022 Dec 14. Neurology. 2023. PMID: 36517236 Free PMC article.
-
Correlations between cerebrospinal fluid homovanillic acid and dopamine transporter SPECT in degenerative parkinsonian syndromes.J Neural Transm (Vienna). 2023 Apr;130(4):513-520. doi: 10.1007/s00702-023-02611-y. Epub 2023 Mar 4. J Neural Transm (Vienna). 2023. PMID: 36871130 Free PMC article.
-
Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.Neurochem Res. 2003 Aug;28(8):1145-50. doi: 10.1023/a:1024255208563. Neurochem Res. 2003. PMID: 12834252
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources